Untargeted Metabolomics of Fermented Rice Using UHPLC Q-TOF MS/MS Reveals an Abundance of Potential Antihypertensive Compounds

• Main Authors: Eric Banan-Mwine Daliri, Fred Kwame Ofosu, Ramachandran Chelliah, Joong-Hark Kim, Jong-Rae Kim, Daesang Yoo, Deog-Hwan Oh
• Format: Article
• Language: English
• Published: MDPI AG 2020-07-01
• Series: Foods
• Subjects: bioactive peptides; hypertension; phenolic compounds; functional food
• Online Access: https://www.mdpi.com/2304-8158/9/8/1007

Enzyme treatment and fermentation of cereals are known processes that enhance the release of bound bioactive compounds to make them available for bioactivity. In this study, we tested the angiotensin converting enzyme (ACE) inhibitory ability of destarched rice, Prozyme 2000p treated destarched rice (DP), and fermented DP samples. Prozyme 2000p treatment increased the ACE inhibitory ability from 15 ± 5% to 45 ± 3%. Fermentation of the Prozyme 2000p treated samples with <i>Enterococcus faecium</i> EBD1 significantly increased the ACE inhibitory ability to 75 ± 5%, while captopril showed an ACE inhibition of 92 ± 4%. An untargeted metabolomics approach using Ultra-high-performance liquid tandem chromatography quadrupole time of flight mass spectrometry revealed the abundance of vitamins, phenolic compounds, antioxidant peptides, DPP IV inhibitory peptides, and antihypertensive peptides in the fermented samples which may account for its strong ACE inhibition. Although fermented DP had decreased fatty acid levels, the amount of essential amino acid improved drastically compared to destarched rice. Our results show that fermenting Prozyme-treated destarched rice with <i>Enterococcus faecium</i> EBD1 generates abundant bioactive compounds necessary for developing antihypertensive functional foods.